fig1
Figure 1. (a) Magnetic resonance imaging 3 months after finishing radiotherapy during temozolomide monotherapy; (b) response after two cycles of fotemustine and bevacizumab treatment
Figure 1. (a) Magnetic resonance imaging 3 months after finishing radiotherapy during temozolomide monotherapy; (b) response after two cycles of fotemustine and bevacizumab treatment
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/